EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Lung Adenocarcinoma With Bone Metastases: Clinicogenomic Profiling and Insights Into Prognostic Factors

Ahmed H Al Sharie iD, Rami K Jadallah, Mahmoud Z Al-Bataineh, Lana E Obeidat, Hanin Lataifeh, Mahmoud I Tarad, Mustafa Q Khasawneh, Walaa Almdallal, Tamam El-Elimat, Feras Q Alali

Cancer Control · 2025

DOI: 10.1177/10732748251325587 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Control, 2025. Verfasst von Ahmed H Al Sharie und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Microbiology, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan. Hauptthemen laut MEDLINE: Bone Neoplasms, Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Qatar University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Lung adenocarcinoma is the leading cause of cancer-related mortality worldwide. Understanding the clinicopathological profiles and genomic drivers of its metastatic patterns is a crucial step for risk stratification. Herein, we investigated the clinicogenomic features of bone metastases in lung adenocarcinoma and their prognostic value.

Methods

A retrospective cohort study with a total of 4064 patients with various metastatic patterns of lung adenocarcinoma were included, obtaining relevant clinical data and genomic profiles. Patients were categorized based on the presence or absence of bone metastases. A comparative analysis of both groups in terms of demographics, disease status, somatic mutations, and microsatellite instability was carried out. Significantly different variables were tested for their association with bone metastases. Cox regression analyses were utilized to identify independent survival prognostic variables in the bone metastases sub-cohort.

Results

Gender, concomitant metastases (to adrenal gland, nervous system, lymph nodes, liver, lung, mediastinum, pleura, and skin), and aberrations in TP53 , EGFR , KEAP1 , and MYC were associated with bone metastases in lung adenocarcinoma. Survival analyses within the bone metastases sub-cohort have illustrated the following variables to possess poor prognostic signature including age > 75, female gender, White ethnicity, distant metastases (adrenal gland, central nervous system, intra-abdominal, and liver), EGFR (wild type), KEAP1 (mutant), MYC (mutant), KRAS (mutant), and SMARCA4 (mutant).

Conclusion

Key clinical and genomic factors associated with lung adenocarcinoma bone metastases have been highlighted, providing exploratory insights into high-risk individuals. Future studies should be directed to validate these prognostic variables in larger, more diverse cohorts to enhance generalizability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone NeoplasmsAdenocarcinoma of LungLung NeoplasmsHumansFemaleMalePrognosisRetrospective StudiesAgedMiddle AgedMutationAged, 80 and overAdultMicrosatellite InstabilityBiomarkers, Tumor

Stichwörter der Autor:innen

MSK-MET cohortbone metastasesclinicopathological predictorslung adenocarcinomanon-small-cell lung cancerprognostic factors

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology and Microbiology, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
  • King Abdullah University Hospital, Irbid, Jordan.
  • Department of Internal Medicine, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
  • Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
  • Italian Hospital, Amman, Jordan.
  • Department of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.

ORCID-Profile: Ahmed H Al Sharie

Förderung

  • Qatar University

Zitieren

APA

Sharie, A. H. A., Jadallah, R. K., Al-Bataineh, M. Z., Obeidat, L. E., Lataifeh, H., Tarad, M. I., Khasawneh, M. Q., Almdallal, W., El-Elimat, T., & Alali, F. Q. (2025). Lung Adenocarcinoma With Bone Metastases: Clinicogenomic Profiling and Insights Into Prognostic Factors. Cancer Control. https://doi.org/10.1177/10732748251325587

Vancouver

Sharie AHA, Jadallah RK, Al-Bataineh MZ, Obeidat LE, Lataifeh H, Tarad MI, et al. Lung Adenocarcinoma With Bone Metastases: Clinicogenomic Profiling and Insights Into Prognostic Factors. Cancer Control. 2025. doi:10.1177/10732748251325587

BibTeX
@article{Sharie2025,
  author = {Sharie, Ahmed H Al and Jadallah, Rami K and Al-Bataineh, Mahmoud Z and Obeidat, Lana E and Lataifeh, Hanin and Tarad, Mahmoud I and Khasawneh, Mustafa Q and Almdallal, Walaa and El-Elimat, Tamam and Alali, Feras Q},
  title = {Lung Adenocarcinoma With Bone Metastases: Clinicogenomic Profiling and Insights Into Prognostic Factors},
  journal = {Cancer Control},
  year = {2025},
  doi = {10.1177/10732748251325587}
}
Kostenlos starten →